Nitronal (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitronal, is an organic nitrate presented as an intravenous solution for intravenous use. It provides rapid vasodilation to relieve chest pain and improve cardiac output in patients with acute angina pectoris, acute heart failure, or hypertensive emergencies.

GNH USA supplies Nitronal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity for critical care environments. The product complies with European Union pharmacopeial standards and is distributed under a prescription‑only status.

Nitronal (glyceryl trinitrate) is used in the management of acute cardiovascular conditions that require rapid vasodilation.

Acute angina pectoris: rapid relief of chest pain by dilating coronary arteries. Acute heart failure: improves cardiac output and reduces preload. Hypertensive emergencies: lowers systemic vascular resistance to control severe blood pressure spikes.

Adverse reactions may occur with intravenous glyceryl trinitrate administration.

Common Side Effects: - Headache: throbbing pain often triggered by vasodilation. - Flushing: warmth and redness of the skin. - Hypotension: drop in blood pressure causing dizziness. - Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects: - Severe hypotension: profound blood pressure fall requiring emergency intervention. - Methemoglobinemia: abnormal hemoglobin leading to cyanosis. - Allergic reaction: rash, itching or anaphylaxis.

When using Nitronal, careful monitoring and specific precautions are required.

Dose titration: adjust infusion rate based on blood pressure and symptom relief. Concurrent nitrate therapy: avoid to prevent additive hypotension. Hypotension risk: monitor blood pressure continuously during administration. Cardiac surgery: discontinue before operative procedures to reduce bleeding risk. Pregnancy: use only if potential benefit justifies potential risk to the fetus. Store below 25°C: keep in original container, protect from light and moisture.

Glyceryl trinitrate may interact with several drug classes, altering its safety profile.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors: can cause profound hypotension. - Other vasodilators: additive blood pressure lowering effect. - Sodium nitrite: increases nitrite levels, enhancing toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia response. - Calcium channel blockers: may enhance hypotensive effect. - Diuretics: may increase volume depletion and hypotension.